<!DOCTYPE html>
<html  lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  <head>
    <meta charset="utf-8" />
<script async src="https://www.googletagmanager.com/gtag/js?id=G-273DTKB5QW"></script>
<meta name="description" content="Clinical Investigator" />
<meta name="dcterms.title" content="Americo F. Padilla, M.D./Miami Dade Medical Research Institute - 700447 - 01/17/2025" />
<meta name="dcterms.creator" content="Center for Drug Evaluation and Research" />
<meta name="dcterms.description" content="Clinical Investigator" />
<meta name="dcterms.publisher" content="FDA" />
<meta name="dcterms.source" content="FDA" />
<meta property="og:site_name" content="U.S. Food and Drug Administration" />
<meta property="og:type" content="Article" />
<meta property="og:url" content="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/americo-f-padilla-mdmiami-dade-medical-research-institute-700447-01172025" />
<meta property="og:title" content="Americo F. Padilla, M.D./Miami Dade Medical Research Institute - 700447 - 01/17/2025" />
<meta property="og:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" />
<meta property="og:updated_time" content="Tue, 01/28/2025 - 00:00" />
<meta property="og:street_address" content="8955 Southwest 87th Court, Suite 110" />
<meta property="og:locality" content="Miami" />
<meta property="og:region" content="FL" />
<meta property="og:postal_code" content="33176-2264" />
<meta property="og:country_name" content="US" />
<meta property="article:publisher" content="FDA" />
<meta property="article:published_time" content="Tue, 01/28/2025 - 09:20" />
<meta property="article:modified_time" content="Tue, 01/28/2025 - 00:00" />
<meta name="google-site-verification" content="tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:site" content="@US_FDA" />
<meta name="twitter:title" content="Americo F. Padilla, M.D./Miami Dade Medical Research Institute - 700447 - 01/17/2025" />
<meta name="twitter:creator" content="@US_FDA" />
<meta name="twitter:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<script type="application/ld+json">{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@type": "Article",
            "headline": "Americo F. Padilla, M.D./Miami Dade Medical Research Institute - 700447 - 01/17/2025",
            "name": "Americo F. Padilla, M.D./Miami Dade Medical Research Institute - 700447 - 01/17/2025",
            "description": "Clinical Investigator",
            "image": {
                "@type": "ImageObject",
                "representativeOfPage": "True",
                "url": "/themes/custom/preview/img/FDA-Social-Graphic.png"
            },
            "datePublished": "Tue, 01/28/2025 - 09:20",
            "dateModified": "Tue, 01/28/2025 - 00:00",
            "author": {
                "@type": "Organization",
                "name": "Center for Drug Evaluation and Research"
            },
            "publisher": {
                "@type": "Organization",
                "name": "FDA"
            }
        }
    ]
}</script>
<meta property="og:description" content="Clinical Investigator" />
<meta property="twitter:description" content="Clinical Investigator" />
<link rel="icon" href="/themes/custom/preview/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="alternate" hreflang="en" href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/americo-f-padilla-mdmiami-dade-medical-research-institute-700447-01172025" />
<link rel="canonical" href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/americo-f-padilla-mdmiami-dade-medical-research-institute-700447-01172025" />
<link rel="shortlink" href="https://www.fda.gov/node/424778" />
<script src="/files/google_tag/production/google_tag.script.js?spd7cd" defer></script>

    <title>Americo F. Padilla, M.D./Miami Dade Medical Research Institute - 700447 - 01/17/2025 | FDA</title>
    <link rel="stylesheet" media="all" href="/files/css/css_1reGTN8IJomDe9NNXuGLDghsOFcqPHURMZ3XKurXneU.css?delta=0&amp;language=en&amp;theme=preview&amp;include=eJxlj1GOwjAMRC8UyP6sxG0i1zEhIslEsRdUTg8FUSr2xxqPpZlnPkvMhhFyi9JsKuCz32h3RDO6iqKK3-i9S0AqEqhRmS2z-m_D6awm1U-k4vqQS5arTwUTlZ3aXHJL_2weuZu6CTC1Qd13dFxkuGOkwG9WaSdqLPUBqZ6YMWJGC4a0AOgJwxhR3BKt_jn3FfGvyCsHtZe8JLxu4ffnsDEfL8MaTNSvagXlQbdZ0oc8Un92vfe1fbeC3QF5KozJ" />
<link rel="stylesheet" media="all" href="/files/css/css_xLeUZALg1CD0YmiSIzZnqkwKfNF_g3TkAjkxBt_uccA.css?delta=1&amp;language=en&amp;theme=preview&amp;include=eJxlj1GOwjAMRC8UyP6sxG0i1zEhIslEsRdUTg8FUSr2xxqPpZlnPkvMhhFyi9JsKuCz32h3RDO6iqKK3-i9S0AqEqhRmS2z-m_D6awm1U-k4vqQS5arTwUTlZ3aXHJL_2weuZu6CTC1Qd13dFxkuGOkwG9WaSdqLPUBqZ6YMWJGC4a0AOgJwxhR3BKt_jn3FfGvyCsHtZe8JLxu4ffnsDEfL8MaTNSvagXlQbdZ0oc8Un92vfe1fbeC3QF5KozJ" />

    <script src="https://script.crazyegg.com/pages/scripts/0024/3700.js" async></script>
<script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&amp;subagency=FDA&amp;sdor=fda.gov&amp;dclink=true" language="javascript" id="_fed_an_ua_tag"></script>

            <script>window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag("js", new Date());gtag("set", "developer_id.dMDhkMT", true);gtag("config", "G-273DTKB5QW", {"groups":"default","page_placeholder":"PLACEHOLDER_page_location","allow_ad_personalization_signals":false});</script>
        
  </head>
  <body class="role-anonymous path-node page-node-type-warning-letter has-glyphicons">
      <div id="quicklinks" class="sr-only">
        <ul>
          <li><a href="#main-content" class="sr-only sr-only-focusable" tabindex="1">Skip to main content</a></li>
          <li><a href="#search-form" class="sr-only sr-only-focusable" tabindex="1">Skip to FDA Search</a></li>
          <li><a href="#section-nav" class="sr-only sr-only-focusable" tabindex="1">Skip to in this section menu</a></li>
          <li><a href="#footer-heading" class="sr-only sr-only-focusable" tabindex="1">Skip to footer links</a></li>
        </ul>   
      </div>    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M95XGZW" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
       
  <div class="main-container container-fluid">     <div class="row">
                                                               


	
	<header class="lcds-header container-fluid" role="heading" aria-level="1">
		                    
			<div class="row us-masthead">                            

				<div class="usa-banner col-xs-12">

					<img class="usa-banner__us-flag" src="/themes/custom/preview/assets/images/US_Flag.png" alt="U.S. flag" />

					<span>An official website of the United States government</span>

					<a id="USMenuButton" class="collapsed" data-toggle="collapse" data-target="#USABannerMenu" aria-controls="USABannerMenu">Here’s how you know <span class="toggle-indicator"> </span></a>
          			<div class="col-xs-12 collapse usa-banner__menu" id="USABannerMenu" aria-labelledby="USMenuButton">


						<div id="gov-banner" class="row usa-banner-content usa-grid usa-accordion-content" aria-hidden="true">
							      <div class="col-xs-12 col-sm-6 col-md-3">
							        <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-dot-gov.svg" alt="Dot gov" style="width:3em;">
									<div class="usa-media_block-body">
								      <p><strong>The .gov means it’s official.</strong><br>Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.</p>
								    </div>
							      </div>
							      <div class="col-xs-12 col-sm-6 col-md-3">
							        <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-https.svg" alt="SSL" style="width:3em;">
							        <div class="usa-media_block-body">
								         <p><strong>The site is secure.</strong><br> The <strong>https://</strong> ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.</p>
							        </div>
							      </div>
						</div>
					</div>

				</div>
			</div> 						<div class="alert alert-warning margin-left-neg-2 margin-right-neg-2 margin-top-3 margin-bottom-1"> 
				<p>On Oct. 1, 2024, the FDA began implementing a <a href="/about-fda/fda-organization/fda-modernization-efforts-establishing-unified-human-foods-program-new-model-field-operations-and" title="FDA Modernization Efforts for Establishing a Unified Human Foods Program, New Model for Field Operations and More">reorganization</a> impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.</p> 
			</div>

						<div class="row fda-masthead">
							<div class="col-xs-4 col-md-8"> 
					<a href="/" title="FDA Homepage">
						<h1 class="fda-masthead__fda-logo">U.S. Food and Drug Administration</h1>
					</a>
       	</div>
				
        <div class="col-xs-8 col-md-4">
          <ul class='fda-masthead__item-list'>
            <li><a title="" id="btn-search" class="btn btn-default btn-sm fda-masthead__btn-search">
              <span class="fa fa-search" aria-hidden="true">&nbsp;</span>
              <span class="fda-masthead__btn-label">Search</span>
            </a></li>
            <li><a id="menu-btn" class="btn btn-default btn-sm fda-masthead__btn-menu collapsed" href="#primary-nav" data-toggle="collapse" aria-expanded="true">
              <span class="fa fa-bars" aria-hidden="true">&nbsp;</span>
              <span class='fda-masthead__btn-label'>Menu</span>
            </a></li>
          </ul>
				</div>
							
						<form class="fda-masthead__search sr-only" role="search" action="/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8" >
							
							<div class="search-popover" id="search-popover">
								<div class="input-group pull-right" id="search-group">
									<label class="sr-only" for="search-query">Search FDA</label>
									
									<input class="form-control search-input" id="search-query" name="s" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA"  type="text" /> 
									
									<span class="input-group-btn" id="input-group-btn">
										
										<button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button>

									</span>

								</div>
							</div>
																				
						</form>					

			</div> 
		<nav id="primary-nav" class="lcds-primary-nav row collapse">					<div class="col-md-5 col-lg-4">
						<section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
							<h2 class="lcds-primary-nav__group-heading">Featured</h2>
							<ul class="lcds-primary-nav__list lcds-primary-nav__list--featured">
								<li class="lcds-primary-nav__list-item"><a href="https://www.safetyreporting.hhs.gov/smarthub#/" title="Report a Problem with an FDA Regulated Product">Report a Product Problem</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/about-fda/contact-fda">Contact FDA</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/regulatory-information/search-fda-guidance-documents">FDA Guidance Documents</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/safety/recalls-market-withdrawals-safety-alerts">Recalls, Market Withdrawals and Safety Alerts</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/news-events/newsroom/press-announcements">Press Announcements</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/advisory-committees">Advisory Committees</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/fda-en-espanol">En Espa&#241ol</a></li>
							</ul>
						</section>
					</div>

					<div class="col-md-7 col-lg-8">
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Products</h2>
            <ul class="lcds-primary-nav__list">
							<li class="lcds-primary-nav__list-item"><a href="/food">Food</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/drugs">Drugs</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/medical-devices">Medical Devices</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/radiation-emitting-products">Radiation-Emitting Products</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/vaccines-blood-biologics">Vaccines, Blood, and Biologics</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/animal-veterinary">Animal and Veterinary</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/cosmetics">Cosmetics</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/tobacco-products">Tobacco Products</a></li>
            </ul>
          </section>
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Topics</h2>
            <ul class="lcds-primary-nav__list">
							<li class="lcds-primary-nav__list-item"><a href="/about-fda">About FDA</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/combination-products">Combination Products</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/regulatory-information">Regulatory Information</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/safety">Safety</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/emergency-preparedness-and-response">Emergency Preparedness</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/international-programs">International Programs</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/news-events">News and Events</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/training-and-continuing-education">Training and Continuing Education</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections and Compliance</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/science-research">Science and Research</a></li>
            </ul>
          </section>
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Information For</h2>
            <ul class="lcds-primary-nav__list">
	            <li class="lcds-primary-nav__list-item"><a href="/consumers">Consumers</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/patients">Patients</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/industry">Industry</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/health-professionals">Health Professionals</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/federal-state-local-tribal-and-territorial-officials">Federal, State and Local Officials</a></li>
            </ul>
          </section>
					</div>
	      </nav>
    </header>

<div class="col-xs-12">
	<div data-drupal-messages-fallback class="hidden"></div>

</div>

                              
                                                                     <section id="block-entityviewcontent" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      

<a class="lcds-button--expandable collapsed hidden-md hidden-lg" data-toggle="collapse" href="#section-nav" >In this section<span class="visible-sm-inline-block">:

                Warning Letters
    
    </span>
</a>

<nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav hidden-md hidden-lg collapse">

    <ul class="lcds-section-nav__list">

      <li>

              <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" title="Warning Letters" class="lcds-section-nav__section-link lcds-section-nav__link lcds-section-nav__parent-link visible-xs-block visible-sm-block">
                                        Warning Letters
                    </a>

                        <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_5 js-view-dom-id-be9ee9bb1eaababa3d15bbb8bbd3b48d8e3e4adb2cb32bf4654c684c004b2166">
  
    
      
  
      <div>
  
  <ul class="lcds-section-nav__section-link__active lcds-section-nav__list">

          <li><a href="/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/about-warning-and-close-out-letters" class="lcds-section-nav__link">About Warning and Close-Out Letters</a></li>
    
  </ul>

</div>


  
          </div>
</div>


                        <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_2 js-view-dom-id-9d39545401c8295585d9dfa8786f2157e90ba6d4cd8d62369129b1d6eadee451">
  
    
      
  
          </div>
</div>


      </li>

    </ul>

</nav>

  </section>

<section id="block-entityviewcontent-15" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      
    <ol class="lcds-breadcrumb visible-md visible-lg">
          <li >
                  <a href="/">Home</a>
              </li>
          <li >
                  <a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections, Compliance, Enforcement, and Criminal Investigations</a>
              </li>
          <li >
                  <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities">Compliance Actions and Activities</a>
              </li>
          <li >
                  <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a>
              </li>
          <li >
                  <a class="current-link">Americo F. Padilla, M.D./Miami Dade Medical Research Institute - 700447 - 01/17/2025</a>
              </li>
      </ol>




<ol class="lcds-breadcrumb visible-sm visible-xs">
  <li>
    <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" title="Warning Letters">
     Warning Letters
    </a>
  </li>
</ol>

  </section>






                                
      <main>

                                 <article id="main-content" class="article main-content container-fluid" role="article">
          
                                                                <header class="row content-header" role="heading" aria-level="1">
                         <section id="block-entityviewcontent-8" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      
<div class="col-sm-12 col-md-8 col-md-offset-2">

        <p class="content-type-label text-center">WARNING LETTER</p>
      <h1 class="text-center content-title">Americo F. Padilla, M.D./Miami Dade Medical Research Institute
            
      <span class="font-family-sans">
                  MARCS-CMS 700447 —           <time datetime="2025-01-17T00:00:00Z">January 17, 2025</time>
</span></h1>


    
<div class="lcds-toolbar lcds-toolbar--social">
      <ul class="lcds-share lcds-share--default">
    <li class="lcds-share__item">
      <a href="https://www.facebook.com/sharer/sharer.php?u=https://www.fda.gov%2Finspections-compliance-enforcement-and-criminal-investigations%2Fwarning-letters%2Famerico-f-padilla-mdmiami-dade-medical-research-institute-700447-01172025" class="lcds-share__btn lcds-share--default__btn-facebook js-share" id="fb-share" target="_blank"><span class="fa icon-facebook" aria-hidden="true"></span>Share</a>
    </li>
    <li class="lcds-share__item">
      <a href="https://x.com/intent/tweet/?text=Americo%20F.%20Padilla%2C%20M.D.%2FMiami%20Dade%20Medical%20Research%20Institute%20-%20700447%20-%2001%2F17%2F2025&amp;url=https://www.fda.gov%2Finspections-compliance-enforcement-and-criminal-investigations%2Fwarning-letters%2Famerico-f-padilla-mdmiami-dade-medical-research-institute-700447-01172025" target="_blank" class="lcds-share__btn lcds-share--default__btn-x-twitter js-share" id="twitter-share">
        <svg class="icon-svg-inline" aria-hidden="true">
          <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter">
        </svg>
        Post
      </a>
    </li>
    <li class="lcds-share__item hidden-xs">
      <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.fda.gov%2Finspections-compliance-enforcement-and-criminal-investigations%2Fwarning-letters%2Famerico-f-padilla-mdmiami-dade-medical-research-institute-700447-01172025&amp;title=Americo%20F.%20Padilla%2C%20M.D.%2FMiami%20Dade%20Medical%20Research%20Institute%20-%20700447%20-%2001%2F17%2F2025&amp;source=FDA" class="lcds-share__btn lcds-share--default__btn-linkedin js-share" id="linkedin-share" target="_blank"><span class="fa icon-linkedin" aria-hidden="true"></span>Linkedin</a>
    </li>

    <li class="lcds-share__item">
      <a href="mailto:?subject=Americo%20F.%20Padilla%2C%20M.D.%2FMiami%20Dade%20Medical%20Research%20Institute%20-%20700447%20-%2001%2F17%2F2025&amp;body=https://www.fda.gov%2Finspections-compliance-enforcement-and-criminal-investigations%2Fwarning-letters%2Famerico-f-padilla-mdmiami-dade-medical-research-institute-700447-01172025" class="lcds-share__btn lcds-share--default__btn-mail"><span class="fa icon-envelope" aria-hidden="true"></span>Email</a>
      </li>
    <li class=" lcds-share__item hidden-xs">
      <a href="javascript:window.print();" title="Print this page" class="lcds-share__btn lcds-share--default__btn-print"><span class="fa icon-print" aria-hidden="true"></span>Print</a>
    </li>
  </ul>
  <div class="form-group">
    
  </div>
</div>
 
</div>

  </section>






                      </header>
                              
                                                                           <div class="col-md-8 col-md-push-2" role="main">

                            
                            
                            
                            
                                              
  
 

                 

  <hr>
 

<div class="inset-column">
  <dl class="lcds-description-list--grid">

              <dt class="cell-1_1">Delivery Method:</dt> 
        <dd class="cell-2_1">VIA UNITED PARCEL SERVICE AND VIA E-MAIL
                                                                                                                                                                                                                                                                                                                                                                                                                              </dd>
      
              <dt class="cell-1_2">Reference #:</dt> 
        <dd class="cell-2_2">25-HFD-45-01-01</dd>
      
              <dt class="cell-1_3">Product:</dt> 
        <dd class="cell-2_3">Drugs                          
            
            
            
            
            
            
            
             
            
            
            
              
            
            
            </dd>
      
          </dl>
  </div>            


<hr>

<div class="row inset-column">
  <div class="col-xs-12 col-md-6">
    <dl class="">

        <dt>Recipient:</dt>

                      <dd></dd>
                    
            <dd>Americo F. Padilla, M.D./Miami Dade Medical Research Institute</dd>

          
                      <dd><p class="address" translate="no"><span class="address-line1">8955 Southwest 87th Court, Suite 110</span><br>
<span class="locality">Miami</span>, <span class="administrative-area">FL</span> <span class="postal-code">33176-2264</span><br>
<span class="country">United States</span></p></dd>
          
          
          
    </dl>
  </div>            

       <div class="col-xs-12 col-md-6">
    <dl class="">
          
          <dt>Issuing Office:</dt>
        
         
          <dd>Center for Drug Evaluation and Research (CDER)</dd>
        
         
          <dd><p class="address" translate="no"><span class="country">United States</span></p></dd>
        
        
        
        
        
    </dl>
    <dl class=""> 
      
    </dl>
  </div>  
      
</div>

 

 

<hr>

<p class="text-align-center"><strong>WARNING LETTER</strong></p><p class="text-align-center">FDA Ref. No.: 25-HFD-45-01-01</p><p>Dear Dr. Padilla:</p><p>This Warning Letter informs you of objectionable conditions observed during the U.S. Food and Drug Administration (FDA) inspection conducted at your clinical site between February 1 and February 16, 2024. Investigator Richard A. Lyght, representing FDA, reviewed your conduct of the following clinical investigations:</p><ul><li>Protocol <strong>(b)(4)</strong> (also referred to as Protocol <strong>(b)(4)</strong>), “<strong>(b)(4)</strong>,” of the investigational drug <strong>(b)(4)</strong>), performed for <strong>(b)(4)</strong> (formerly performed for <strong>(b)(4)</strong>)</li><li>Protocol <strong>(b)(4)</strong>, “<strong>(b)(4)</strong>),” of the investigational drug <strong>(b)(4)</strong>, performed for <strong>(b)(4)</strong></li></ul><p>This inspection was conducted as a part of FDA’s Bioresearch Monitoring Program, which includes inspections designed to evaluate the conduct of research and to help ensure that the rights, safety, and welfare of human subjects have been protected.</p><p>At the conclusion of the inspection, Investigator Lyght presented and discussed with you the Form FDA 483, Inspectional Observations. We acknowledge receipt of your February 28, 2024, written response to the Form FDA 483, and your subsequent correspondence dated March 4, 2024.</p><p>From our review of the FDA Establishment Inspection Report, the documents submitted with that report, and your written responses dated February 28, 2024, and March 4, 2024, it appears that you did not adhere to the applicable statutory requirements in the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) and applicable regulations contained in Title 21 of the Code of Federal Regulations, part 312 (21 CFR 312) governing the conduct of clinical investigations and the protection of human subjects. We wish to emphasize the following:</p><p><strong>You failed to obtain informed consent in accordance with the provisions of 21 CFR part 50 [21 CFR 312.60; 21 CFR 50.20; 21 CFR 50.27; 21 CFR 50.52; 21 CFR 50.55].</strong></p><p>As a clinical investigator, you are required to obtain informed consent, and to comply with additional specific obligations, in accordance with 21 CFR part 50. FDA's regulations at 21 CFR 50.20 state that, except as provided in 21 CFR 50.23 and 21 CFR 50.24, no investigator may involve a human being as a subject in research covered by the regulations unless the investigator has obtained the legally effective informed consent of the subject or the subject’s legally authorized representative. Except as provided in 21 CFR 56.109(c), informed consent shall be documented by the use of a written consent form approved by the Institutional Review Board (IRB) and signed and dated by the subject or the subject’s legally authorized representative at the time of consent (21 CFR 50.27).</p><p>Additionally, for children in clinical investigations that involve greater than minimal risk with the prospect of direct benefit to individual subjects, FDA’s regulations at 21 CFR 50.52(c) require adequate provisions to be made for soliciting the assent of children and the permission of their parents or guardians as set forth in 21 CFR 50.55. Permission by a parent or guardian must be documented in accordance with and to the extent required by 21 CFR 50.27 (21 CFR 50.55(f)).</p><p>You failed to adhere to these requirements. Protocol <strong>(b)(4)</strong> was a clinical trial involving children and adolescents, ages ≥6 to &lt;18 years. The IRB determined that Protocol <strong>(b)(4)</strong> was a research study that meets the criteria found in the risk category described in 21 CFR 50.52. As a result, you were required to obtain the permission of a parent or guardian, which must be documented in accordance with and to the extent required by 21 CFR 50.27.</p><p>You failed to obtain legally effective written consent from two subjects before their enrollment in Protocol <strong>(b)(4)</strong>, because you did not obtain permission from the subjects’ parent or guardian before the subjects’ enrollment in the study. Specifically:</p><p>1. Subject <strong>(b)(6)</strong> was enrolled in Protocol <strong>(b)(4)</strong> on October 10, 2022; completed a 28-day Screening Phase; and was randomized on November 9, 2022. Before enrollment, on October 10, 2022, the subject’s sibling signed the informed consent as the subject’s parent or guardian; however, the subject’s sibling is not the subject’s parent or guardian. Parental permission was not obtained from the subject’s parent until <strong>(b)(6)</strong>, approximately 10 months after Subject <strong>(b)(6)</strong> was enrolled in the study.</p><p>2. Subject <strong>(b)(6)</strong> was enrolled in Protocol <strong>(b)(4)</strong> on November 16, 2022; completed a 28-day Screening Phase; and was randomized on December 15, 2022. Before enrollment, on November 16, 2022, the subject’s uncle signed the informed consent as the subject’s parent or guardian; however, the subject’s uncle is not the subject’s parent or guardian. Parental permission was not obtained from the subject’s parent until <strong>(b)(6)</strong>, approximately 9 months after Subject <strong>(b)(6)</strong> was enrolled in the study.</p><p>In your February 28, 2024, written response, you explained that the root cause for this observation was errors and deficiencies in the documentation process of legal guardians’ representatives regarding participation in the study. You indicated that as a corrective action, the subject and their parent returned to the site to consent, confirming parental agreement for study participation. You also indicated that as a preventive action, you will ensure that proper documentation for consent of minors is captured in accordance with 21 CFR 50.27, and that you would work with your quality assurance department to implement a process for obtaining documentation, such as a court-issued legal guardianship document. You also noted that permission from parents or guardians will be documented in a separate form that will be completed before any study procedures are done.</p><p>We acknowledge your statement that you will implement corrective and preventive actions to ensure compliance with 21 CFR 50.27. However, despite your statements, we remain concerned that you did not obtain written consent from the parent or legally authorized representative of two subjects before enrolling the subjects and administering investigational product. We are particularly concerned about the severity of the violations and their potential effect on subjects’ rights, since pediatric subjects are considered a vulnerable population.</p><p>Furthermore, we are unable to undertake an informed evaluation of the adequacy of your response because you did not provide sufficient details regarding the procedures implemented at your site as part of your corrective action plan to prevent similar violations in the future. For example, your written response does not provide sufficient details about how you will ensure proper documentation for the consent of minors, or about your plan to implement a process of obtaining documentation in coordination with your quality assurance department. Your explanation, when taken into consideration with the violations described above, suggests systemic failures in your conduct of clinical investigations. Without these details, we are unable to determine whether your corrective actions appear adequate to help prevent similar violations in the future.</p><p>We emphasize that as the clinical investigator, you are ultimately responsible for compliance with all applicable FDA regulations governing the conduct of clinical investigations and the protection of human subjects, including obtaining legally effective informed consent from subjects before their enrollment.</p><p>Your failure to obtain informed consent in accordance with 21 CFR part 50 before involving pediatric subjects in research jeopardizes the safety and welfare of subjects and raises concerns about whether subjects had an adequate opportunity to fully assess the risks and benefits of their participation in the clinical investigation.</p><p>This letter is not intended to be an all-inclusive list of deficiencies with your clinical study of an investigational drug. It is your responsibility to ensure adherence to each requirement of the law and relevant FDA regulations. You should address any deficiencies and establish procedures to ensure that any ongoing or future studies comply with FDA regulations.</p><p>This letter notifies you of our findings and provides you with an opportunity to address the deficiencies noted above. Within 15 business days of your receipt of this letter, you should notify this office in writing of the actions you have taken to prevent similar violations in the future. Failure to address this matter adequately may lead to regulatory action. If you believe that you have complied with the FD&amp;C Act and relevant regulations, please include your reasoning and any supporting information for our consideration.</p><p>Should you have any questions or concerns regarding this letter or the inspection, please email FDA at CDER-OSI-Communications@fda.hhs.gov. Your written response and any pertinent documentation should be addressed to:</p><p>Brittany L. Garr-Colón, MPH<br>Branch Chief<br>Compliance Enforcement Branch<br>Division of Enforcement and Postmarketing Safety<br>Office of Scientific Investigations<br>Office of Compliance<br>Center for Drug Evaluation and Research<br>U.S. Food and Drug Administration<br>Building 51, Room 5352<br>10903 New Hampshire Avenue<br>Silver Spring, MD 20993</p><p>Sincerely yours,<br>{See appended electronic signature page}<br>David C. Burrow, Pharm.D., J.D.<br>Director<br>Office of Scientific Investigations<br>Office of Compliance<br>Center for Drug Evaluation and Research<br>U.S. Food and Drug Administration</p><p>Cc: Americo F. Padilla, M.D.<br>New Med Research Inc.<br>115 South 21st Avenue<br>Hollywood, Florida 33020</p><p>Americo F. Padilla, M.D.<br>New Med Research Inc.<br>17325 NW 27th Avenue, Suite 111<br>Miami Gardens, Florida 33056<br><br>--------------------------------------------------------------------------------------------<br>This is a representation of an electronic record that was signed electronically. Following this are manifestations of any and all electronic signatures for this electronic record.<br>--------------------------------------------------------------------------------------------<br>/s/<br>------------------------------------------------------------<br>DAVID C BURROW<br>01/17/2025 06:21:25 AM</p>

<!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET-->
<!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET-->



              
                                            
              
            </div>

                                                                                  <aside class="col-md-2 col-md-push-2" role="complementary">
                  <section id="block-entityviewcontent-4" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

        <div class="region region-">
  <aside class="lcds-card lcds-card--border-top">
    <ul role="menu" class="lcds-description-list">
      
                            


























  <li role="menuitem" class="node-current-date lcds-description-list__item">
    <div>
      <h2 class="lcds-description-list__item-heading">Content current as of:</h2>
      <p class="lcds-description-list__item-text"><time datetime="2025-01-28T00:00:00Z">01/28/2025</time>
</p>
    </div>
  </li>
               
                
<li role="menuitem" class="lcds-description-list__item">  
	<div>
		
		 <h2 class="lcds-description-list__item-heading">Regulated Product(s)</h2>
		 <ul role="menu" class="lcds-metadata-list">
						  <li role="menuitem">Drugs</li>
			  			     			  						              
			
			
			
			
			
			
			
			
					</ul>
	 
			     
						       

			  
						  

			  
						 
	</div>
</li>   

    </ul>

  </aside>
</div>


  </section>


                </aside>
            

                                                                                <aside class="col-md-2 col-md-pull-10" role="complementary">
                  <section id="block-entityviewcontent-3" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

        <div class="region region-">
    <p class="text-center "><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" class="btn btn-default"><i class="fa fa-arrow-circle-left" aria-hidden="true"></i> More Warning Letters</a></p>

     
    <nav id="section-nav"class="lcds-card lcds-section-nav lcds-section-nav--side hidden-xs hidden-sm">
      <ul class="lcds-section-nav__list lcds-section-nav--side__list">
        <li>

                    <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" title="Warning Letters" class="lcds-section-nav__link lcds-section-nav--side__link lcds-section-nav__parent-link lcds-section-nav--side__parent-link">
                                        Warning Letters
                      </a>

          
                        <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_4 js-view-dom-id-aa70933444d09fb42e66435f5378c75a6bd18e24be17eeda7f88432e70bcc38b">
  
    
      
  
      <div class="item-list">
  
  <ul class="lcds-section-nav__active lcds-section-nav__list lcds-section-nav--side__list">

          <li><a href="/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/about-warning-and-close-out-letters" class="lcds-section-nav__link lcds-section-nav--side__link">About Warning and Close-Out Letters</a></li>
    
  </ul>

</div>


  
          </div>
</div>


        </li>
      </ul> 
    </nav>
  </div>    

  </section>


                </aside>
            
                 </article>        
      </main>

    </div>  </div>

                <div class="region region-subscribe">
    <section id="block-entityviewcontent-5" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      

  </section>


  </div>

  
      <footer class="lcds-footer container-fluid">
        
    <div class="row lcds-footer__primary">
    <h2 id="footer-heading" class="sr-only">Footer Links</h2>
    <nav class="text-center">
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/about-fda/about-website/fdagov-archive" >FDA Archive</a></li>
          <li><a href="/about-fda" >About FDA</a></li>
          <li><a href="/about-fda/about-website/internet-accessibility" >Accessibility</a></li>
        </ul>
      </div>
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/about-fda/visitor-information" >Visitor Information</a> </li>
          <li><a href="/about-fda/about-website/website-policies" >Website Policies / Privacy</a></li>
          <li><a href="/about-fda/jobs-and-training-fda/no-fear-act" >No FEAR Act</a></li>
          <li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" >Vulnerability Disclosure Policy</a></li>
        </ul>
      </div>
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/regulatory-information/freedom-information" title="Freedom of Information Act">FOIA</a></li>
          <li><a href="https://www.hhs.gov/" title="Health and Human Services" target="_blank">HHS.gov</a></li>
          <li><a href="https://www.usa.gov/" target="_blank">USA.gov</a></li>
        </ul>
      </div>
    </nav>
  </div>
    <div class="row lcds-footer__secondary">
    <div class="col-sm-12 col-md-6 col-lg-4 lcds-footer__social-links">
      <a href="/about-fda/contact-fda" class="btn btn-default btn-md">Contact FDA</a>
      <a href="https://www.facebook.com/FDA" title="Follow FDA on Facebook" class="no-disclaimer"> 
        <span class="fa fa-facebook fa-2x" aria-hidden="true">
          <span class="sr-only">Follow FDA on Facebook</span> 
        </span>
      </a>
      <a href="https://x.com/US_FDA" title="Follow FDA on X" class="no-disclaimer">
        <svg class="icon-svg-inline fa-2x" aria-hidden="true">
          <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter">
        </svg>
        <span class="sr-only">Follow FDA on X</span>
      </a>
      <a href="https://instagram.com/FDA" title="Follow FDA on Instagram" class="no-disclaimer">
        <span class="fa fa-instagram fa-2x" aria-hidden="true"> 
          <span class="sr-only">Follow FDA on Instagram</span>
        </span>
      </a>
      <br class='visible-xs-inline'/>
      <a href="https://www.linkedin.com/company/fda/" title="Follow FDA on LinkedIn" class="no-disclaimer">
        <span class="fa fa-linkedin fa-2x" aria-hidden="true"> 
          <span class="sr-only">Follow FDA on LinkedIn</span>
        </span>
      </a>
      <a href="https://youtube.com/@US_FDA" title="View FDA videos on YouTube" class="no-disclaimer">
        <span class="fa fa-youtube fa-2x" aria-hidden="true"> 
          <span class="sr-only">View FDA videos on YouTube</span>
        </span>
      </a>
      <a href="/about-fda/contact-fda/subscribe-podcasts-and-news-feeds" title="Subscribe to FDA RSS feeds">
        <span class="fa fa-rss fa-2x" aria-hidden="true">
          <span class="sr-only">Subscribe to FDA RSS feeds</span>
        </span>
      </a>
    </div>
    <a href="/" title="FDA Homepage">
        <div class="visible-lg-block col-lg-4 text-center lcds-footer__logo">
          <span class="sr-only">FDA Homepage</span>
        </div>
    </a>
    <div class="col-sm-12 col-md-6 col-lg-4 text-center lcds-footer__contact-number">
      <span class="fa fa-phone" aria-hidden="true"> </span> 
     <span class="sr-only">Contact Number</span>
      1-888-INFO-FDA (1-888-463-6332)
    </div>
  </div>
  
      <!--END WEBSITE FEEDBACK SNIPPET-->
  

    </footer>
    <a href="" id="btn-top" class="btn btn-primary btn-top"><span class="sr-only">Back to </span>Top</a>
  
  </div>

    
    <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/424778","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"fda_ckeditor_enhancements":{"basePath":"modules\/custom\/fda_ckeditor_enhancements"},"google_analytics":{"account":"G-273DTKB5QW","trackOutbound":true,"trackMailto":true,"trackTel":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click"},"ajax":[],"user":{"uid":0,"permissionsHash":"3aef67b4ac7d861d8624bf1f7ab2bc9cfc56d3c25b7d709dc15466dfa996dfb0"}}</script>
<script src="/files/js/js_KwaVrVDnb9vBN4UOzg4J4320oQW-EMMozpPhvFZziRU.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=preview&amp;include=eJxlj1GOwjAMRC8UyP6sxG0i1zEhIslEsRdUTg8FUSr2xxqPpZlnPkvMhhFyi9JsKuCz32h3RDO6iqKK3-i9S0AqEqhRmS2z-m_D6awm1U-k4vqQS5arTwUTlZ3aXHJL_2weuZu6CTC1Qd13dFxkuGOkwG9WaSdqLPUBqZ6YMWJGC4a0AOgJwxhR3BKt_jn3FfGvyCsHtZe8JLxu4ffnsDEfL8MaTNSvagXlQbdZ0oc8Un92vfe1fbeC3QF5KozJ"></script>

  <script type="text/javascript"  src="/iJN07Z4KRN9-g6ACNFL4/u9zYtwS4kcGLi7YE/R3weTgo7RAE/TWhQIm0/JW1o"></script></body>
</html>
